Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Gastroenterol ; 106(7): 1246-54, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21670772

ABSTRACT

OBJECTIVES: Viral factors are considered the best predictors of response to treatment for chronic hepatitis C (CHC), but genetic factors are known to have an important role in this respect. This paper investigates the relationships among the host genetic factors HLA and IL28B, viral factors, and the outcome of combination therapy. METHODS: A multicenter retrospective cohort of 428 previously untreated CHC patients was treated with pegylated interferon/ribavirin (pegIFN/RBV) for 48 weeks. In all, 378 (88%) of these patients were genotype 1 or 4, and 50 (12%) were genotype 2 or 3. RESULTS: Multivariate logistic regression showed the rs12979860 CC genotype (adjusted odds ratio (aOR)=4.3, 95% confidence interval (95% CI): 2.6-7), the HLA-DQB1*0301 allele (aOR=2.08, 95% CI: 1.2-3.5) and age, viral genotype, and viral load levels to be significantly associated with sustained virological response (SVR). When the variable rs12979860 was eliminated, the area under the receiver operating characteristic (ROC) curve (AUC) decreased significantly (0.76 vs. 0.69; P=0.03). AUC values derived from viral factors were lower than those corresponding to host genetic factors (0.67 vs. 0.72, respectively; P=0.04). The HLA-DQB1*0301 and A*0201 alleles were associated with rs12979860 CC genotype and SVR (P<0.0001). CONCLUSIONS: The HLA-DQB1*0301 allele and IL28B genotype are factors that are associated independently with SVR. There is a synergism between the HLA-DQB1*0301 and HLA-A*0201 alleles with polymorphism rs12979860 CC, which increases the SVR rate. IL28B genotype is the best predictor of SVR.


Subject(s)
Antiviral Agents/therapeutic use , Genes, MHC Class II/genetics , Genes, MHC Class I/genetics , Hepatitis C, Chronic/drug therapy , Interferon-alpha/therapeutic use , Interleukins/genetics , Ribavirin/therapeutic use , Adult , Alleles , Area Under Curve , Drug Therapy, Combination , Female , Genotype , Hepatitis C, Chronic/genetics , Hepatitis C, Chronic/pathology , Humans , Interferon alpha-2 , Interferons , Logistic Models , Male , Polyethylene Glycols/administration & dosage , ROC Curve , Recombinant Proteins , Retrospective Studies , Viral Load/drug effects
2.
Hepatology ; 53(6): 1830-8, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21413051

ABSTRACT

UNLABELLED: The vertical transmission of hepatitis C virus (HCV-VT) is a major route of HCV infection in children, but the risk factors remain incompletely understood. This study analyzed the role of interleukin 28B (IL28B) in HCV-VT and in the spontaneous clearance of HCV among infected infants. Between 1991 and 2009, 145 mothers were recruited for this study: 100 were HCV-RNA+ve / human immunodeficiency virus negative (HIV-ve), with 128 children, and 33 were HCV-RNA-ve/HCV antibody+ve, with 43 children. The infants were tested for HCV-RNA at birth and at regular intervals until the age of 6 years. IL28B (single nucleotide polymorphism rs12979860) was determined in the mothers and children. HCV-VT was assumed when children presented HCV-RNA+ve in two subsequent blood samples. HCV-VT-infected infants were categorized as: (1) transient viremia with posterior HCV-RNA-ve and without serum-conversion; (2) persistent infection with serum-conversion. Of the 31 mothers with CC polymorphism, 19 (61%) were HCV-RNA+ve, whereas among the 68 mothers with non-CC polymorphism, 56 (82%) were HCV-RNA+ve. In all, 26 of 128 (20%) infants born to the HCV-RNA+ve mothers acquired HCV infection, but only 9 (7%) were chronically infected. The rate of HCV-VT was higher among the mothers with higher HCV viremia. No HCV-VT was detected in the HCV-RNA-ve women. Neither the mothers' nor the childrens' IL-28 status was associated with an increased risk of HCV-VT. The factors influencing viral clearance among the infected children were genotype non-1 and genotype CC of IL28B. In logistic regression, child CC polymorphism was the only predictor of HCV-clearance in HCV genotype-1. CONCLUSION: High maternal viral load is the only predictive factor of HCV-VT. IL28B plays no role in HCV-VT, but IL28B CC child polymorphism is associated independently with the spontaneous clearance of HCV genotype-1 among infected children.


Subject(s)
Hepacivirus , Hepatitis C/transmission , Infectious Disease Transmission, Vertical , Interleukins/genetics , Polymorphism, Single Nucleotide/genetics , Pregnancy Complications, Infectious/genetics , Child , Child, Preschool , Female , Genotype , Hepacivirus/genetics , Hepatitis C/blood , Hepatitis C/epidemiology , Humans , Infant , Infant, Newborn , Interferons , Logistic Models , Male , Predictive Value of Tests , Pregnancy , Pregnancy Complications, Infectious/blood , RNA, Viral/blood , Retrospective Studies , Risk Factors , Viral Load
SELECTION OF CITATIONS
SEARCH DETAIL
...